India is considering imposing an anti-dumping duty on import of two variants of anti-bacterial drug pencilin to protect the domestic industry from cheap Chinese and Mexican shipments.
"The provisional anti-dumping duty to be imposed on Penicillin-G Potassium and 6-Amino Penicillanic Acid would range between $18.54 per billion oxford units (BOU) and $2.10 per BOU," a commerce ministry official said.
The Directorate General of Anti-dumping and Allied Duties (DGAD) in its preliminary findings has suggested the Commerce Ministry to impose the duty to check the damage done to the domestic industry, the official said.
However, the imposition of the anti-dumping duty is notified by the finance ministry.
Acting on complaints from the Vadodara-based Alembic and Chennai-based Southern Petrochemical Industries Corporation (SPIC), DGAD, the nodal investigating agency, had initiated the probe into dumping of the two products from China and Mexico.
In its recommendations, DGAD has said the products have been exported to India below its normal value.
"The domestic industry has suffered material injury," DGAD said, adding that the damage has been caused by these imports from China. However, a section of the Indian industry, including some multinationals, has opposed the government move saying that the production of the two bulk drugs in the country is not enough to meet the domestic demand and if the anti-dumping duty is imposed, it may create a sort of monopoly in the domestic market.
Countries initiate anti-dumping probe to see whether their domestic industries have been hurt because of surge in cheap imports. As a counter measure, they impose duties within the multilateral regime of the WTO.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
